| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 4,650 | $30 | $120.9K |
| J0897 | Injection, denosumab, 1 mg | 5,940 | $20 | $106.9K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 8,750 | $10 | $96.3K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 2,030 | $30 | $68.8K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 16,000 | $1 | $64K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 710 | $60 | $40.4K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 410 | $80 | $33.5K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 3,990 | $10 | $31.9K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 220 | $100 | $20.8K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 170 | $50 | $9K |